Carmen Herranz Ors

Carmen Herranz Ors is a cancer researcher at the Wellcome Sanger Institute, with an academic background spanning genetics, biomedical research and biomedicine. She completed her BSc in Genetics at the Universitat Autònoma de Barcelona, followed by an MSc in Biomedical Research and a PhD in Biomedicine at Universitat Pompeu Fabra in Barcelona, Spain. Her PhD research focused on lymphangioleiomyomatosis, a rare disease, exploring biomarkers and potential therapeutic approaches. At the Wellcome Sanger Institute, Carmen has held two roles, progressing from Postdoctoral Fellow to Principal Bioinformatician. Her research focuses on cancer biology and the genetic mechanisms underlying tumour development, combining genomic and CRISPR-based approaches at scale using cancer patient-driven organoids to investigate cancer vulnerabilities and advance cancer research